DECEMBER 31, 2011 10-K

Company

Actinium Pharmaceuticals, Inc.

Filed

April 12, 2012

Period of Report

December 31, 2011

Accession Number

0001078782-12-001008

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →